“now we know the astonishing truth that some patients are waiting a year or more just to get treatment. it’s simply not good enough.”.
the publication’s purpose is to be a "force for good and a platform for much needed change and to generate critical debate"..
'indian ip and liabilities law barrier to pharma r&d investment'
. poll: can technology solve irish border issue after brexit? .
.copyright © 2018 the daily californian, the independent berkeley student publishing co., inc..